Capecitabine-induced multifocal leukoencephalopathy: a report of five cases.

Videnovic, A; Semenov, I; Chua-Adajar, R; Baddi, L; Blumenthal, D T; Beck, A C; Simuni, T; Futterer, S et al. · Neurology · 2005

case_series · Level IV

Where this comes from

Abstract

Capecitabine is used to treat advanced breast and gastrointestinal malignancies. A single case of encephalopathy and three cases of peripheral neuropathy are the only neurotoxicities reported. The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.

Medical subject headings